V. Kouranos, S. Ward, M. Kokosi, S. Thomas, D. Castillo, E. Judge, F. Tonder, A. Devaraj, T. Maher, E. Renzoni, A. Wells
{"title":"Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and prognosis","authors":"V. Kouranos, S. Ward, M. Kokosi, S. Thomas, D. Castillo, E. Judge, F. Tonder, A. Devaraj, T. Maher, E. Renzoni, A. Wells","doi":"10.1183/13993003.CONGRESS-2018.PA5210","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA5210","url":null,"abstract":"Background: The ATS/ERS guideline definition of obstructive pattern in lung function tests does not consider measurement of static lung volumes as mandatory. Methods: Patients with pulmonary sarcoidosis (n=1110; 529 males) were enrolled. Static volumes expected in association with an obstructive process was quantified in a control cohort of COPD patients (n=899; 536 males). Ventilatory defects in sarcoidosis patients, were defined according to ATS/ERS and with the reclassification of a sub-group of patients from obstructive to mixed disease, based on TLC values below those expected in the control COPD cohort. Results: A prevalence of 10.4% of mixed disease was identified, which was associated with a higher prevalence of chest radiographic stage IV disease (p The comparison of static lung volumes between sarcoidosis with obstructive pattern (n=329) and COPD patients revealed lower static lung volumes in sarcoidosis patients, (TLC%predicted: 96.6±11.8 vs 121±17.8, p Conclusion: Mixed disease may be underestimated in sarcoidosis using current ATS/ERS guidelines despite its high prognostic value in sarcoidosis.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128494782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Boccabella, C. Macaluso, M. Kokosi, V. Alfieri, C. Stock, V. Kouranos, G. Margaritopoulos, L. Mori, J. Barnett, P. Molyneaux, P. George, F. Chua, T. Maher, S. Desai, J. Jacob, A. Devaraj, A. Wells, E. Renzoni
{"title":"Pulmonary function trends predict mortality in patients with hypersensitivity pneumonitis","authors":"Cristina Boccabella, C. Macaluso, M. Kokosi, V. Alfieri, C. Stock, V. Kouranos, G. Margaritopoulos, L. Mori, J. Barnett, P. Molyneaux, P. George, F. Chua, T. Maher, S. Desai, J. Jacob, A. Devaraj, A. Wells, E. Renzoni","doi":"10.1183/13993003.CONGRESS-2018.OA2155","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.OA2155","url":null,"abstract":"Background: Hypersensitivity pneumonitis (HP) varies in widely behaviour, from self-limiting disease to inexorably progressive lung scarring. Given its unpredictability, we set out to assess whether short term changes in lung function could identify patients at risk. Methods: Consecutive adult patients with hypersensitivity pneumonitis attending the RBH ILD clinic and performing PFTs according to ATS guidelines, seen between 2011 and 2014 with at least one follow up lung function test were considered eligible. Results: 205 subjects were included (91 males, age 65.1 ±10, never smokers=135). At baseline, FVC (mean ±SD) was: 66.8±21.6% -FEV1:67.7±20.8% -DLCO: 39.3±15.2%. The diagnosis of HP was reached through MDT consensus. Patients were followed up for a median of 3.7 years (range 0.33 to 7); 89 deaths occurred. A decline in FVC≥10% from baseline, within the first year, and a decline in DLCO by at least 15% over same period, were assessed against mortality. On univariate analysis, a DLCO drop≥15% (HR: 2.4 – 95% CI: 1.5-3.9, p Conclusions: To our knowledge, this is the largest retrospective study to assess short termFVC and DLCO changes in relation to mortality in HP. In this cohort, both a decline in FVC of≥10% and in DLCO ≥15% occurring within the first year, are predictive of survival, suggesting their potential validity as outcome variables in clinical trials in HP.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130625830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Schott, C. Ascoli, Yue Huang, D. Perkins, P. Finn
{"title":"Diminished peripheral T cell activity in sarcoidosis associates with progressive disease.","authors":"C. Schott, C. Ascoli, Yue Huang, D. Perkins, P. Finn","doi":"10.1183/13993003.CONGRESS-2018.OA2156","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.OA2156","url":null,"abstract":"Aims and Objectives: Sarcoidosis is characterized not only by granulomatous inflammation, but diminished peripheral responses. How this “immune paradox” contributes to or results from sarcoidosis pathophysiology remains unclear. To address this question, previous findings in our lab have associated peripheral lymphopenia with worse lung disease, but have yet to identify any core pathways. We aim to identify immunological mechanisms that define peripheral responses in sarcoidosis and contribute to progressive disease. Methods: To identify mechanisms of immune dysregulation specific to sarcoidosis, we utilized the Gene Expression Omnibus and identified peripheral blood mononuclear cell microarray data from controls (n = 20), sarcoidosis (n = 38), and hypersensitivity pneumonitis (n = 6) patients in GSE19314. Weighted gene correlation network analysis was used to construct gene network modules. Gene ontology pathways were determined for significant networks using the Gene Ontology Consortium database. Results: 5 modules of gene expression were significantly under-expressed and 5 were significantly over-expressed in sarcoidosis. Despite similarities in clinical presentations, no significant modules were shared between sarcoidosis and hypersensitivity pneumonitis patients. One module under-expressed in sarcoidosis was specifically associated with declining lung function, and consisted of pathways related to anabolism and T cell activation. Conclusions: Our findings suggest that decreased anabolism and impaired peripheral T cell activation are not only markers of sarcoidosis, but may also contribute to disease progression.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"84 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113970408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amal Durakovic, K. Fuursted, K. Larsen, Matiullah Naqibullah, S. Shaker
{"title":"Microbiological study of mediastinal lymph node biopsy from patients with sarcoidosis and lung cancer","authors":"Amal Durakovic, K. Fuursted, K. Larsen, Matiullah Naqibullah, S. Shaker","doi":"10.1183/13993003.congress-2018.pa5202","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa5202","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126230226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rahul K. Sharma, S. Natarajan, D. Prajapat, D. Talwar
{"title":"Role of Impulse oscillometry(IOS)in diagnosing small airway dysfunction in patients with ILD-A prospective observational study","authors":"Rahul K. Sharma, S. Natarajan, D. Prajapat, D. Talwar","doi":"10.1183/13993003.CONGRESS-2018.PA5211","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA5211","url":null,"abstract":"Background: ILDs are known to cause structural alterations in peripheral airways. Conventional tests like spirometry and HRCT chest are not very sensitive to diagnose small airway dysfunction(SAD) in ILD. IOS can be used as non-invasive, easy to perform method to reliably detect and measure early onset SAD in ILD patients thus offering potential pharmaceutical benefits. Objective: To assess the frequency of SAD in ILD patients using IOS and correlate its findings with spirometric parameters Methods: This prospective observational study enrolled 123 consecutive patients, aged>20years, diagnosed as ILD(clinical, radiological or histopathological basis as per ATS/ERS criteria) between 2016-2017. Cardiac patients and acutely ill patients were excluded from study. All patients underwent spirometry, IOS and HRCT chest; outcome parameters were recorded in a prestructured Performa and correlated statistically. Results: Out of total, 26%(n=32) were found to have SAD on IOS with mean age 60.91±8.7years and female predominance(75%). Majority had symptom duration between 3-7 years(n=21) and etiology as hypersensitivity pneumonitis(n=10), sarcoidosis(n=9) and CTD-ILD(n=8). FEV1, FVC, FEV1/FVC ratio and FEF25% were significantly negatively correlated with R5, R5-20, D5-20%, AX and significantly positively correlated with X5. On ROC curve, X5(AUC=77.8%) and AX(AUC=77.9%) had highest diagnostic ability to detect SAD on IOS. Conclusion: IOS is a good modality to detect small airway dysfunction in early stages and certain occupational ILD where spirometry may remain normal and can be used as an adjunct to spirometry both for diagnosis and follow up of therapeutic outcomes in ILD.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"204 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115720093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H. Ohira, K. Yoshinaga, Shinya Sakiyama, Toshitaka Nakaya, Naoko Suzuki, Ayako Sugimoto, Akiko Hayashishita, Tadao Aikawa, Takahiro Sato, O. Manabe, N. Oyama-Manabe, Taku Watanabe, M. Nishimura, I. Tsujino
{"title":"Risk of underdiagnoses of cardiac sarcoidosis by routine electrocardiogram and echocardiogram in patients with biopsy-proven extracardiac sarcoidosis","authors":"H. Ohira, K. Yoshinaga, Shinya Sakiyama, Toshitaka Nakaya, Naoko Suzuki, Ayako Sugimoto, Akiko Hayashishita, Tadao Aikawa, Takahiro Sato, O. Manabe, N. Oyama-Manabe, Taku Watanabe, M. Nishimura, I. Tsujino","doi":"10.1183/13993003.CONGRESS-2018.OA2154","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.OA2154","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"126 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116031028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Puja Sohal, Hina Aggarwal, K. Madan, V. Hadda, K. Luthra, A. Mohan, D. Mitra, R. Guleria
{"title":"ETS-1 mRNA and its association with T-BET and Th1 cytokine expression in active pulmonary sarcoidosis","authors":"Puja Sohal, Hina Aggarwal, K. Madan, V. Hadda, K. Luthra, A. Mohan, D. Mitra, R. Guleria","doi":"10.1183/13993003.congress-2018.pa5203","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa5203","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126455378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease","authors":"M. Labor, G. Pavlisa, M. Alilović","doi":"10.1183/13993003.CONGRESS-2018.PA3002","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA3002","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"217 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133550959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jeanette Boyd, R. Baughman, Dominique Valeyere, A. Rodríguez, Linda Charvoz, H. Faber, Chris Knoet, F. Martone, D. Novel, Bernd Quadder, Jack Richardson, G. Spitzer, G. Ziosi, J. Hochreiter
{"title":"Sarcoidosis treatment and outcomes: what is most important to patients?","authors":"Jeanette Boyd, R. Baughman, Dominique Valeyere, A. Rodríguez, Linda Charvoz, H. Faber, Chris Knoet, F. Martone, D. Novel, Bernd Quadder, Jack Richardson, G. Spitzer, G. Ziosi, J. Hochreiter","doi":"10.1183/13993003.CONGRESS-2018.PA5219","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA5219","url":null,"abstract":"Purpose of Study: A sarcoidosis treatment guidleine is being developed by a European Respiratory Society (ERS) working group. The sarcoidosis support groups were asked to provide input regarding what outcomes were most important to the patient. Methods: Sarcoidosis support groups in collaboration with the European Lung Foundation developed an outcome survey that was translated into six languages. Individual outcomes were given overall titles and defintiions for each outcome were provided. Patients were asked to rank each outcome on a 5 point scale from 1 (extremely important) to 5 (not important at all). Results: To date, 778 individuals have completed the survey in their native langauge: 270 German, 158 English, 147 Italians. 112 Dutch, 73 Spanish, and 8 French using an online survey. The eight outcomes and scores were: quality of life (1.41); Functionality (1.43); Survival (1.69); Imaging (1.84); Adverse events (1.86); Blood tests (1.98); Pulmonary function tests (2.06). All outcomes ranged from Extremely important (1) to Very important (2). Of the outcomes, quality of life and functionality were the most important, while blood tests and pulmonary function tests were less important outcomes. Imaging was ranked as a more important outcome than blood or pulmonary function tests. Conclusion: Sarcoidosis patients ranked treatments which improved quality of life and functionality as most important outcomes. Patients ranked adverse events as a less important outcome than quality of life, survival, and functionality.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131043432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ken Akao, Takuya Okamura, T. Minezawa, Kumiko Yamatsuta, Yasuhiro Goto, S. Isogai, M. Kondo, K. Imaizumi
{"title":"Flow cytometric analysis of lymphocyte profiles in mediastinal lymph nodes","authors":"Ken Akao, Takuya Okamura, T. Minezawa, Kumiko Yamatsuta, Yasuhiro Goto, S. Isogai, M. Kondo, K. Imaizumi","doi":"10.1183/13993003.CONGRESS-2018.PA5204","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA5204","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128510314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}